Home / Explore Insights / Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
/ Insights / Explore Insights / Rituximab Versus Cyclophosphamide For Anca Associated Vasculitis
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
Stone JH, Merkel PA, Spiera R, Seo P, Langford C, Hoffman G, Kallenberg C, St. Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Witzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U
New England Journal of Medicine
ITN
07/14/2010
Publication